Sincerus Pharmaceuticals’ Transformational Approach to Customized Dermatologic Medicines Attracts Institutional Investors
October 02, 2019 10:00 ET
|
Decathlon Capital Partners
POMPANO BEACH, FL, Oct. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Sincerus Pharmaceuticals, the parent company of Prescriber’s Choice and the nation’s leading innovator in providing...